These biomarkers, including CYFRA 21-1, NSE, ProGRP, SCC, CEA, tumor M2-PK, CRP, LDH, tumor-suppressor genes, and oncogenes, CA125, CgA, NCAM, and TPA, are useful in the diagnosis and clinical management of lung cancer [77]. This evidence concerns the gene GRP and neoplasm.